Baxter International Inc., commonly referred to as Baxter, is a leading global healthcare company headquartered in the United States. Founded in 1931, Baxter has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices and pharmaceuticals industry, focusing on critical care, renal care, and surgical products. Baxter is renowned for its innovative core products, such as intravenous (IV) solutions, dialysis equipment, and surgical instruments, which are designed to enhance patient outcomes and streamline healthcare delivery. With a commitment to quality and safety, Baxter has achieved significant milestones, including advancements in renal therapies and the development of cutting-edge infusion systems. As a trusted partner in healthcare, Baxter continues to maintain a strong market position, recognised for its dedication to improving patient care worldwide.
How does Baxter's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Baxter's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Baxter International Inc. reported total greenhouse gas emissions of approximately 4,031,000,000 kg CO2e globally. This includes Scope 1 emissions of about 352,000,000 kg CO2e, primarily from stationary combustion, and Scope 2 emissions of approximately 384,000 kg CO2e, with no reported Scope 3 emissions for the year. The company has set ambitious climate commitments, aiming to achieve carbon neutrality for its direct operations by 2040 and reduce absolute Scope 1 and 2 GHG emissions by 25% by 2030, using 2020 as the base year. Baxter's previous targets included a 45% reduction in GHG emissions indexed to revenue from a 2005 baseline, which was set to be achieved by 2015. The company has made significant strides, having reported a 7% absolute reduction in emissions from 2005 to 2010, exceeding its initial target of a 20% reduction indexed to revenue. Baxter's commitment to sustainability is further demonstrated by its ongoing efforts to maintain carbon neutrality at its headquarters in Deerfield, Illinois, and its manufacturing facility in Cartago, Costa Rica, through the use of certified renewable energy and carbon offsets. The emissions data and reduction targets are sourced from Baxter International Inc., reflecting the company's dedication to transparency and accountability in its climate initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2005 | 2006 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Baxter's Scope 3 emissions, which decreased by 10% last year and decreased by approximately 7% since 2009, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 45% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baxter has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
